["{\"step_by_step_thinking\": \"The question is about nintedanib improving response rate in patients with bladder cancer. However, none of the provided documents mention nintedanib or bladder cancer. The documents are related to various types of cancers such as melanoma, uterine body cancer, breast cancer, and soft part sarcoma. Therefore, it is not possible to draw a conclusion based on these documents.\", \"answer_choice\": \"B\"}"]